Proactive Investors - Run By Investors For Investors

Buds & Duds: Cannabis stocks stumble on first trading day in March

The North American Marijuana Index, which tracks leading cannabis stocks in the US and Canada, failed to keep pace with gains on Wall Street
cannabis plants
Tilray closed on its move to buy Manitoba Harvest, the world's largest hemp food manufacturer

Cannabis stocks looked poised to end the week on a disappointing note, with most of the major players in the US and Canada on the decline.

The North American Marijuana Index, which tracks leading cannabis stocks in the US and Canada, failed to keep pace with the gains on Wall Street and shed 1.3% to hit 290.50.


There were very few buds to choose from Friday, but 1933 Industries (CSE:TGIF) (OTCQX:TGIFF) made its way onto the list of gainers, adding 1.9% to hit C$0.53 in Canadian trade.

This week, the company released a new educational short film, The Dawn of a New Era, by documentary filmmaker Atlee James. The movie tells the story of weed from the dawn of civilization through its prohibition to the current trend pushing towards legalization.


The list of duds, meanwhile, was lengthy and included Tilray (NASDAQ:TLRY), which reversed direction mid-morning and fell 2.55% to $79.24.

The Canadian cannabis behemoth announced late Thursday that it has closed on its move to pay C$419 million to buy Manitoba Harvest, a Winnipeg, Manitoba based company which bills itself as the world’s largest hemp food manufacturer.

The deal allows the cannabis company to forge ahead in the lucrative market for cannabidiol (CBD), which is derived from hemp plants as well as sell hemp foods and supplements.

Joining the laggards as well was Green Growth Brands Inc of Columbus, Ohio, which slipped by 3% to hit $3.60.

The company recently revealed its plans to set up 400 sales kiosks to market its CBD (cannabidiol) lotions and other sorts of products this year in malls and retailers like DSW stores, the shoe specialist.

CEO Peter Horvath also said this week that he remains committed to Green Growth’s all-stock hostile bid for its Canadian rival Aphria (NYSE:APHA).

Aphria last month rebuffed Green Growth’s bid, which put its value at roughly C$2.35 billion (US:$1.76 billion) on the view that it “significantly undervalued” the company and is “inadequate”. Green Growth offered Aphria stakeholders 1.5714 shares of Green Growth stock for each Aphria share.

Aphria shares were also among the duds and lost 2% to hover at $10.15.

Also trading lower on no reported news were Aurora Cannabis (TSE:ACB), which shed 1.4% to C$9.78; Curaleaf Holdings (CSE:CURA), which fell 2.8% to C$10.12; and MariMed Inc (OTCQB:MRMD), which dropped 2.6% to US$3.80.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

muffins and cannabis
November 29 2018
Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time
cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
FSD Pharma facility
June 11 2019
The indoor hydroponic facility will be optimized for large-scale, medical-grade cannabis production and once complete, is expected to have over 3.9 million sq/ft available for production
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use